ReviewSubstance abuse and rehabilitation2022
The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy.
Review in Substance abuse and rehabilitation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
108 citing papers in PubMed, 197 citations in OpenAlex.
- Promoting substance use stigma resistance through an automated text message intervention (project RESTART): Outcomes of a pilot feasibility trial.Journal of substance use and addiction treatment · 2025Trial
- The relationship of pain intensity and opioid craving with delayed methadone dose: A preliminary study of individuals with opioid use disorder.British journal of clinical pharmacology · 2024Trial
- Does implementation of office based addiction treatment by a nurse care manager increase the duration of OUD treatment in primary care? A secondary analysis of the PROUD randomized control trial.Drug and alcohol dependence · 2024Trial
- Barriers and motivators for opioid deprescribing among Danish adults receiving long-term treatment with short-acting opioids: an exploratory qualitative study in primary care informed by self-determination theory.Scandinavian journal of primary health care · 2026Article
- Personal Trauma and Professional Exposure: A Sequential Explanatory Mixed-Methods Study Exploring Factors Influencing HIV Healthcare Workers' Harm Reduction Acceptability.AIDS and behavior · 2026Article
- What We Do Matters: A Documentary Style Video to Address Healthcare Stigma Toward People Who Use Substances.Substance use & addiction journal · 2026Article
- Methadone Versus Buprenorphine/Naloxone: Treatment Outcome Differences Among Individuals Receiving Medications for Opioid Use Disorders in Rural Treatment Settings-A 1-Year Retrospective Cohort Study.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2026Article
- New trends in the overdose epidemic: postural impact on abusers of fentanyl and xylazine and clinical and forensic implications.Forensic science, medicine, and pathology · 2026Review
- Depressive Symptoms and Anticipated Help-seeking Stigma as Mental Healthcare Navigation Barriers Among People Who Use Opioids.Community mental health journal · 2026Article
- Scoping evidence review on the prevention and treatment of opioid overdose.Harm reduction journal · 2026Review
- Perceptions of Buprenorphine With Naloxone Treatment and the Fear of Precipitated Withdrawal: A Qualitative Exploration With HIV Prevention Trials Network 094 INTEGRA Participants and Staff.Drug and alcohol review · 2026Article
- Opioid Message Fatigue in the United States: Prevalence and Associations with Stigma and Policy Support.Substance use & misuse · 2026Article
- "The alternative is they're not getting care at all": a qualitative interview study of opioid use disorder treatment providers' perspectives on quality and appropriateness of telehealth for buprenorphine access.Harm reduction journal · 2026Article
- Telemedicine and increased retention in medications for opioid use disorder treatment.Addiction science & clinical practice · 2026Article
- Stigma toward individuals with cannabis use disorder across age groups: associations with familiarity and sociodemographic characteristics.Harm reduction journal · 2026Article
- Understanding quality of life in chronic non-cancer pain: untangling the associations between medication use, psychosocial functioning, and stigma.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
- Patients With Chronic Pain and Their Perspectives on Barriers and Opportunities for Earlier Opioid Tapering-A Qualitative Study Using Patient Journey Mapping.Musculoskeletal care · 2026Article
- Integrating Harm Reduction and Trauma-Informed Care in Undergraduate Dental Education.Journal of dental education · 2026Article
- Discovery and Optimization of Potent and Subtype-Selective Urea-Derived NaACS medicinal chemistry letters · 2026Article
- Changes in community health worker knowledge and perspectives following opioid overdose prevention and response training.Harm reduction journal · 2026Article
48 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Illicit drug use disorders are the most stigmatised health conditions worldwide, and stigma acts as a meaningful barrier to treatment entry and treatment provision. In the context of dramatically rising opioid-related harms, it is critical that we understand the drivers of stigma and how it affects opioid use disorder treatment and policy. The aim of this narrative review is to discuss how opioid-related stigma impacts treatment provision and harm reduction, and provide potential strategies to reduce stigma at a social and structural level. We used the Framework for Integrating Normative Influences on Stigma (FINIS) to identify sources of opioid-related stigma at the macro (structural stigma), meso (public stigma) and micro (internalised stigma) levels. Reducing stigma requires strategies that target multiple levels, however addressing inequity in the laws, regulations, and rules that segregate people with opioid and other substance use disorders from mainstream society is essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.